Encounter for screening for malignant neoplasm of other genitourinary organs Notes: Vaginal pap smear status-post hysterectomy for non-malignant condition ; code to identify acquired absence of uterus ...
Z13.22 Encounter for screening for metabolic disorder Notes: Encounter for screening for cholesterol level ; Encounter for scre…
Encounter for screening for metabolic disorder Notes: Encounter for screening for cholesterol level ; Encounter for screening for hypercholesterolemia ; Encounter for screening for hyperlipidemia
Z13.7 Encounter for screening for genetic and chromosomal anomalies Notes: genetic testing for procreative management (Z31.4-)
Encounter for screening for genetic and chromosomal anomalies Notes: genetic testing for procreative management (Z31.4-)
Z13.88 Encounter for screening for disorder due to exposure to contaminants Notes: those exposed to contaminants without suspec…
Encounter for screening for disorder due to exposure to contaminants Notes: those exposed to contaminants without suspected disorders (Z57.-, Z77.-)
Z15.8 Genetic susceptibility to other disease Notes: multiple endocrine neoplasia [MEN] syndromes (E31.2-)
Genetic susceptibility to other disease Notes: multiple endocrine neoplasia syndromes (E31.2-)
Z16.3 Resistance to other antimicrobial drugs Notes: Drug resistance NOS ; Resistance to quinine and related compounds ; Resis…
Resistance to other antimicrobial drugs Notes: Drug resistance NOS ; Resistance to quinine and related compounds ; Resistance to tuberculostatics ; Resistance to antimycobacterial drug NOS ; resistanc ...
Z18.09 Other retained radioactive fragments Notes: Other retained depleted isotope fragments ; Retained nontherapeutic radioact…
Other retained radioactive fragments Notes: Other retained depleted isotope fragments ; Retained nontherapeutic radioactive fragments
Z19 Hormone sensitivity malignancy status Notes: Castrate resistant prostate malignancy status ; malignant neoplasm – see Ta…
Hormone sensitivity malignancy status Notes: Castrate resistant prostate malignancy status ; malignant neoplasm - see Table of Neoplasms, by site, malignant